Compare Lumia (LUMIA) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lumia vs Enzyme — how do they compare? Lumia trades at Rp1,414 (market cap Rp246,75M, Rp44,94M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Lumia is the larger of the two by market cap, and Lumia's supply is capped (173,7M / 238,9M LUMIA (73%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Lumia for 31 Days and Enzyme for 29 Days on average.
| LUMIA | MLN | |
|---|---|---|
Market Cap | Rp246,75M | Rp134,13M |
Volume (24h) | Rp44,94M | Rp104,56M |
Circulating Supply | 173,7M / 238,9M LUMIA (73%) | 3,3M MLN |
Typical Hold Time | 31 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lumia trades at Rp1,358.92 with neutral technical signals and bearish moving averages. The token shows moderate network activity with 73% circulating supply and 31-day average hold time. Current price sits between key support at Rp1,325 and resistance at Rp1,423, indicating consolidation phase with ADX signaling strong trend potential.
Overall outlook remains neutral with potential breakout above Rp1,423 resistance. Key opportunities include strong ADX momentum signals, while risks involve limited liquidity and crypto market volatility. Investors should monitor volume patterns for trend confirmation.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Lumia
Lumia is the first next-generation blockchain offering a comprehensive solution for the entire life cycle of real-world assets (RWAs), from asset tokenization to liquidity aggregation and connectivity with millions of DeFi and Web3 traders.
Read more on LUMIA →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
